MétaCan
Menu
Back to cohort
Record W4407285574 · doi:10.1093/jcag/gwae059.221

A221 GENERALIZABILITY OF RANDOMIZED CONTROLLED TRIALS TO ROUTINE CLINICAL CARE IN ULCERATIVE COLITIS

2025· article· en· W4407285574 on OpenAlexaffabout
Tarun Chhibba, Alexandra Frolkis, Lance L. Stein, S Lee, Kevin E. Schill, E Mitseva, Apn Cnp Diane E. Judge, M Martin, K Novak, Cathy Lu, M Chan, Tushar Shukla, Cynthia H. Seow, Gilaad G. Kaplan, A Ananthakrishnan, Remo Panaccione, Christopher Ma

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsUniversity of AlbertaUniversity of CalgaryUniversity of Toronto
Fundersnot available
KeywordsGeneralizability theoryUlcerative colitisRandomized controlled trialMedicineInternal medicineIntensive care medicinePsychologyDisease

Abstract

fetched live from OpenAlex

Abstract Background Historically, randomized controlled trials (RCTs) have been criticized for being poorly generalizable to patients with ulcerative colitis (UC) evaluated in routine care. Aims We aimed to evaluate the proportion of patients with UC starting an advanced therapy who would be eligible to participate in phase 3 registrational UC RCTs. Methods We conducted a retrospective cohort analysis of UC patients starting vedolizumab, ustekinumab, or tofacitinib at two IBD clinics at the University of Calgary. Patient charts, endoscopy reports, and laboratory results were reviewed, and compared against the inclusion and exclusion criteria from five RCTs (GEMINI-I, UNIFI, OCTAVE, ELEVATE, and LUCENT). The proportion of patients who would have been deemed eligible vs. ineligible for trial participation at the time of starting a new advanced therapy was determined. Results A total of 125 patients with UC were included: 78 (62.4%) would have been eligible for at least one of the considered RCTs (Table 1). Trial-eligible patients were younger, less likely to be exposed to prior immunosuppressants, and had higher C-reactive protein and fecal calprotectin. The most common reason for trial ineligibility was having inadequate disease activity at baseline (Mayo endoscopy subscore <2 or absence of rectal bleeding). A significantly greater proportion of patients would have been eligible for LUCENT (44.9%) compared to GEMINI-I (24.8%), OCTAVE (35.2%), or ELEVATE (35.2%) (p<0.01 for all comparisons) (Figure 1). Conclusions Half of patients with UC starting advanced therapy in routine care may be eligible for participation in phase 3 RCTs. Disease activity is the primary reason for trial exclusion. Funding Agencies None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Direct model labels (unvalidated)

Per-model category and study-design labels from the labeling rounds. They are machine output, unvalidated, and the disagreement between models ships as data. No study design here is MEDLINE-validated yet.

Model armCategoriesStudy designConfidence
gemmano category
Domain: not available · Genre: Empirical
About the Canadian research system: no · About a Canadian topic: no
Randomized triallow
gptMetaresearch
Domain: Methods · Genre: Empirical
About the Canadian research system: no · About a Canadian topic: no
Observationallow
models splitAgreement compares identical category sets and study designs across arms.

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.685
metaresearch head score (Gemma)0.838
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: Methods
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.315
Threshold uncertainty score0.388

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.6850.838
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0090.014
Bibliometrics0.0090.010
Science and technology studies0.0020.013
Scholarly communication0.0100.008
Open science0.0050.006
Research integrity0.0070.006
Insufficient payload (model declined to judge)0.0100.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.296
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Labeled directly by 2 models reading the full record.

Metaresearch

The models disagree on parts of this classification; every voice is preserved in the section at the end of the page.

Study designRandomized trial · Observational
DomainMethods
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of GastroenterologySame topicInflammatory Bowel DiseaseCategoryMetaresearchFrench-language works237,207